Teva Loses Amgen Spying Suit Over Blood Drug Secrets

Law360, Los Angeles (April 30, 2013, 8:26 PM EDT) -- A California federal judge on Monday dismissed a suit alleging Amgen Inc. hired a “competitive intelligence” consulting firm to steal trade secrets about Teva Pharmaceuticals USA Inc.'s generic versions of blood drugs, finding Teva had no factual basis for its misappropriation claim.

U.S. District Judge Cormac J. Carney ruled that Teva's five other claims — including fraud, unfair competition and tortious interference with prospective business advantage — were preempted by the California Uniform Trade Secrets Act and Teva had not alleged sufficient facts to support its...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Teva Pharmaceuticals USA Inc et al v. Health IQ LLC et al


Case Number

8:13-cv-00308

Court

California Central

Nature of Suit

Patent

Judge

Cormac J. Carney

Date Filed

February 20, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.